Understanding the Lethal Variant of Prostate Cancer: Power of Examining Extremes

被引:106
作者
Aparicio, Ana [1 ]
Logothetis, Christopher J. [1 ]
Maity, Sankar N. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, David H Koch Ctr Appl Res Genitourinary Canc, Unit 0018 6, Houston, TX 77030 USA
关键词
MOLECULAR CHARACTERIZATION; AURORA KINASES; INHIBITOR;
D O I
10.1158/2159-8290.CD-11-0259
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Small cell prostate carcinoma is a lethal variant of castration-resistant prostate cancer. Beltran and colleagues identified overexpression and amplification of both aurora kinase A (AURKA) and the MYCN protooncogene in the small cell prostate carcinomas and propose Aurora kinase A as a potential therapeutic target in this disease subset. Cancer Discovery; 1(6); 466-68. (C) 2011 AACR.
引用
收藏
页码:466 / 468
页数:3
相关论文
共 10 条
[1]   Neuroendocrine Prostate Cancer Xenografts With Large-Cell and Small-Cell Features Derived From a Single Patient's Tumor: Morphological, Immunohistochemical, and Gene Expression Profiles [J].
Aparicio, Ana ;
Tzelepi, Vasiliki ;
Araujo, John C. ;
Guo, Charles C. ;
Liang, Shoudan ;
Troncoso, Patricia ;
Logothetis, Christopher J. ;
Navone, Nora M. ;
Maity, Sankar N. .
PROSTATE, 2011, 71 (08) :846-856
[2]   Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets [J].
Beltran, Himisha ;
Rickman, David S. ;
Park, Kyung ;
Chae, Sung Suk ;
Sboner, Andrea ;
MacDonald, Theresa Y. ;
Wang, Yuwei ;
Sheikh, Karen L. ;
Terry, Stephane ;
Tagawa, Scott T. ;
Dhir, Rajiv ;
Nelson, Joel B. ;
de la Taille, Alexandre ;
Allory, Yves ;
Gerstein, Mark B. ;
Perner, Sven ;
Pienta, Kenneth J. ;
Chinnaiyan, Arul M. ;
Wang, Yuzhuo ;
Collins, Colin C. ;
Gleave, Martin E. ;
Demichelis, Francesca ;
Nanus, David M. ;
Rubin, Mark A. .
CANCER DISCOVERY, 2011, 1 (06) :487-495
[3]   Randomized phase II study of danusertib (D) in second-line metastatic castration- resistant prostate cancer (CRPC). [J].
Bleuse, J. P. ;
Meulenbeld, H. J. ;
Vinci, E. M. ;
Raymond, E. ;
Vitali, G. ;
Santoro, A. ;
Dogliotti, L. ;
Berardi, R. ;
Cappuzzo, F. ;
Tagawa, S. T. ;
Sternberg, C. N. ;
Jannuzzo, M. G. ;
Mariani, M. ;
Petroccione, A. ;
De Wit, R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
[4]   PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer [J].
Carpinelli, Patrizia ;
Ceruti, Roberta ;
Giorgini, Maria Laura ;
Cappella, Paolo ;
Gianellini, Laura ;
Croci, Valter ;
Degrassi, Anna ;
Texido, Gernma ;
Rocchetti, Maurizio ;
Vianello, Paola ;
Rusconi, Luisa ;
Storici, Paola ;
Zugnoni, Paola ;
Arrigoni, Claudio ;
Soncini, Chiara ;
Alli, Cristina ;
Patton, Veronica ;
Marsiglio, Aurelio ;
Ballinari, Dario ;
Pesenti, Enrico ;
Fancelli, Daniele ;
Moll, Jurgen .
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) :3158-3168
[5]   Molecular characterization of prostatic small-cell neuroendocrine carcinoma [J].
Clegg, N ;
Ferguson, C ;
True, LD ;
Arnold, H ;
Moorman, A ;
Quinn, JE ;
Vessella, RL ;
Nelson, PS .
PROSTATE, 2003, 55 (01) :55-64
[6]   Shared and separate functions of polo-like kinases and aurora kinases in cancer [J].
Lens, Susanne M. A. ;
Voest, Emile E. ;
Medema, Rene H. .
NATURE REVIEWS CANCER, 2010, 10 (12) :825-841
[7]   Initial Testing of the Aurora Kinase A Inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP) [J].
Maris, John M. ;
Morton, Christopher L. ;
Gorlick, Richard ;
Kolb, E. Anders ;
Lock, Richard ;
Carol, Hernan ;
Keir, Stephen T. ;
Reynolds, C. Patrick ;
Kang, Min H. ;
Wu, Jianrong ;
Smith, Malcolm A. ;
Houghton, Peter J. .
PEDIATRIC BLOOD & CANCER, 2010, 55 (01) :26-34
[8]   Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma [J].
Otto, Tobias ;
Horn, Sebastian ;
Brockmann, Markus ;
Eilers, Ursula ;
Schuettrumpf, Lars ;
Popov, Nikita ;
Kenney, Anna Marie ;
Schulte, Johannes H. ;
Beijersbergen, Roderick ;
Christiansen, Holger ;
Berwanger, Bernd ;
Eilers, Martin .
CANCER CELL, 2009, 15 (01) :67-78
[9]   Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate [J].
Papandreou, CN ;
Daliani, DD ;
Thall, PF ;
Tu, SM ;
Wang, XM ;
Reyes, A ;
Troncoso, P ;
Logothetis, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3072-3080
[10]  
Westermark UK, 2011, SEMIN CANC BIOL 0809